A key molecular event in CD pathogenesis is the post-translational modification of gluten peptides by transglutaminase 2 (TG2), which enhances their binding to HLA-DQ molecules and promotes CD4<sup>+</sup> T cell activation. This evidence concerns the gene CD4 and Cowden disease.